[Diagnosis and treatment of aspergillosis in the patients with chronic granulomatous disease].
Chronic granulomatous disease is a rare defect of phagocytosis. Increased susceptibility to infections is limited to catalase positive bacteria and fungi. Aspergillus spp was reported as the increased clinical problem and the main cause of the deaths.
Kurenko-Deptuch
Magdalena
M
Oddział Immunologii, Klinika Gastroenterologii, Hepatologii i Immunologii, Instytut Pomnik-Centrum Zdrowia Dziecka. immuno@czd.waw.pl
Wolska-Kuśnierz
Beata
B
Heropolitańska-Pliszka
Edyta
E
Klaudel-Dreszler
Maja
M
Pac
Małgorzata
M
Pietrucha
Barbara
B
Garczewska
Barbara
B
Bernatowska
Ewa
E
D000935:Antifungal Agents / Q000627:therapeutic use; D001228:Aspergillosis / Q000175:diagnosis* / Q000188:drug therapy* / Q000382:microbiology; D001232:Aspergillus fumigatus / Q000302:isolation & purification; D001233:Aspergillus nidulans / Q000302:isolation & purification; D002648:Child; D004797:Enzyme-Linked Immunosorbent Assay; D006105:Granulomatous Disease, Chronic / Q000150:complications* / Q000382:microbiology; D006801:Humans; D016133:Polymerase Chain Reaction
D000935:Antifungal Agents